Monday, September 14, 2009

Hard To Treat Diseases (HTDS) (H1N1) Vaccine Clinical Approval and Production

Hard To Treat Diseases (HTDS) (H1N1) Vaccine Clinical Approval and Production

SHENZHEN, China, Sept 14, 2009 /PRNewswire-FirstCall via COMTEX/ -- HTDS www.htdsmedical.com The Company is pleased to provide the following update to its shareholders and followers on the (H1N1) Vaccine for Mellow Hope Inc, its China based subsidiary and other general business matters. At the beginning of September, Mellow Hope completed the clinical trial of Influenza A (H1N1) Vaccine (Split Virion). The company received the clinical approval from the State Food and Drug Administration (SFDA) http://eng.sfda.gov.cn/eng. Production will be started shortly. LINK

Posted by at

3 comments:

  1. chinniSeptember 14, 2009 at 4:55 PM

    My Man, what is your openion on PWRM, GVBP, NWMT.

    ReplyDelete
  2. chinniSeptember 14, 2009 at 7:55 PM

    LDSR?

    ReplyDelete
  3. MyManSeptember 15, 2009 at 3:13 PM

    To be honest with you I don't have any firm opinion about PWRM, GVBP, NWMT, LDSR as I'm not invested in any of them, my man. I've seen a lot of talk about PWRM, GVBP and LDSR and all four companies look promising at first glance. But I think you would better off doing your own research and checking out what's being said in FavStocks, Seeking Alpha (if anything) the Yahoo and Google boards.

    ReplyDelete

Subscribe to: Post Comments (Atom)